Maintenance will be taking place for Standards Development on Saturday 26th July between 08:00 and 12:00 UK time. Standards Development will be unavailable or will have limited functionality during this time. Please accept our apologies for any inconvenience caused during this essential maintenance work.

We use cookies to give you the best experience and to help improve our website

Find out what cookies we use and how to disable them

BS ISO 11040-8 ISO 11040-8 Prefilled syringes. Part 8: Requirements and test methods for finished prefilled syringes

Source:
ISO
Committee:
CH/212 - IVDs
Categories:
Syringes, needles and catheters
Comment period start date:
Comment period end date:
Number of comments:
0

Comment by:

Scope

This document is applicable to aseptically processed or terminally sterilized finished prefilled syringes (intended for single use only) based on components addressed in ISO 11040-4 or ISO 11040-6, together with a front end closure and a plunger stopper (sealing the back end), for parenteral preparations with focus on quality, functional performance and safety requirements, as well as relevant test methods.

Finished prefilled syringes which have undergone an additional preparation step by the user before injection (e.g. diluent-containing syringes that have been emptied for reconstitution and in which the reconstituted injectable product has been aspirated after reconstitution) are excluded from the scope of this document.

NOTE 1 This document can also be used as a guidance for other types, designs and/or sizes of finished prefilled syringes, e.g. dual chamber prefilled syringes.

NOTE 2 For finished prefilled syringes that are used in needle-based injection systems, see also references ISO 11608-1:2022[1], ISO 11608-2[2], ISO 11608-3[3], ISO 11608-4[4], ISO 11608-5[5], ISO 11608-6[6], ISO 11608-7[7]).

NOTE 3 Attention is drawn to applicable national or regional regulations and pharmacopoeias such as Ph.Eur.[1]1), USP[2]2) or JP[3]3).

NOTE 4 Finished prefilled syringes for parenteral preparations which are medical devices or which, according to the principal mode of action of the product (i.e. the means by which the product achieves its principal intended action), are borderline between medical devices and medicinal products fall within in the scope of this document, even if they are not always regulated as medicinal products.

Read draft and comment

Comment on proposal

Required form fields are indicated by an asterisk (*) character.


Please email further comments to: debbie.stead@bsigroup.com

Follow standard

You are now following this standard. Weekly digest emails will be sent to update you on the following activities:

You can manage your follow preferences from your Account. Please check your mailbox junk folder if you don't receive the weekly email.

Unfollow standard

You have successfully unsubscribed from weekly updates for this standard.

Error